Use of Pulmonary Artery Catheter in Coronary Artery Bypass Graft. Costs and Long-Term Outcomes

• DOI: 10.1371/journal.pone.0117610
• Publication Date: 2015-02-17T13:59:13Z
• Authors: Fei Xu; Qian Wang; Heng Zhang; Sipeng Chen; Hushan Ao
• Keywords: Pulmonary artery catheter

Pulmonary artery catheters (PAC) are used widely to monitor hemodynamics in patients undergoing coronary bypass graft (CABG) surgery. However, recent studies have raised concerns regarding both the effectiveness and safety of PAC. Therefore, our aim was determine effects use PAC on short- long-term health economic outcomes CABG.1361 Chinese who consecutively underwent isolated, primary CABG at Cardiovascular Institute Fuwai Hospital from June 1, 2012 December 31, were included this study. Of all patients, 453 received during operation (PAC group) 908 no therapy (control group). Short-term mortality major complications analyzed with multivariate regression analysis propensity score matched-pair yield two well-matched groups for further comparison.The managed more often intraoperative vasoactive drugs dopamine (70.9% vs. 45.5%; P<0.001) epinephrine (7.7% 2.6%; P<0.001). In addition, costs initial hospitalization higher ($14,535 $13,873, respectively, p = 0.004). neither associated perioperative or complications, nor it adverse cardiac cerebrovascular events. comparison between showed significant differences either baseline characteristics short-term outcomes.There is clear indication any benefit harm managing expensive. That is, increased without thus appears unjustified routine